C. difficile Isolates and Sources | ||
---|---|---|
UNT Strain # | Source | Relevant Characteristics |
UNT 101–1 | Ohio VA Medical Center (Curtis Donskey) | Non-epidemic (Ribotype 014/0), Other Designation VA1 |
UNT 102–1 | Ohio VA Medical Center (Curtis Donskey) | Non-epidemic (Ribotype 660), Other Designation VA10 |
UNT 103–1 | Ohio VA Medical Center (Curtis Donskey) | Non-epidemic (Ribotype 428), REA J-type strain, binary toxin negative, non-epidemic, Other Designation VA 11 |
UNT 104–1 | Ohio VA Medical Center (Curtis Donskey) | Non-epidemic (Ribotype 428), Other Designation UH15 |
UNT 105–1 | Ohio VA Medical Center (Curtis Donskey) | Non-epidemic (Ribotype 053), Other Designation UH18 |
UNT 106–1 | Ohio VA Medical Center (Curtis Donskey) | Epidemic (BI/NAP1, binary toxin positive, Ribotype 027), Other Designation VA5 |
UNT 107–1 | Ohio VA Medical Center (Curtis Donskey) | Epidemic (BI/NAP1, binary toxin positive, Ribotype 027), Other Designation VA17 |
UNT 108–1 | Ohio VA Medical Center (Curtis Donskey) | Epidemic (BI/NAP1, binary toxin positive, Ribotype 027), Other Designation VA20 |
UNT 109–1 | Ohio VA Medical Center (Curtis Donskey) | Epidemic (BI/NAP1, binary toxin positive, Ribotype 027), Other Designation CC20 |
UNT 110–1 | Ohio VA Medical Center (Curtis Donskey) | NAP-1, Epidemic, Other Designation L32 |
UNT 196–1 | ATCC | Epidemic (Ribotype 078), BAA-1875 (Other Designation: 5325), Binary toxin positive, Toxinotype V PFGE tye NAP7, REA type BI 8 |
UNT 210–1 | ATCC | Epidemic (Ribotype 027) BAA-1870; Binary toxin positive, Toxinotype IIIb PFGE tye NAP1, REA type BI 8 |
UNT 008–1 | ATCC | Non-epidemic (Ribotype 012), BAA-1382 |